Cargando…

Drug utilization in neonatal setting of Pakistan: focus on unlicensed and off label drug prescribing

BACKGROUND: Unlicensed and off label drug use is an issue recognized worldwide in pediatric pharmacotherapy. The study was designed to assess the prevalence and predictors of unlicensed and off label drug use in neonatal population of Pakistan. METHOD: A prospective, observation study was conducted...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aamir, Muhammad, Khan, Jamshaid Ali, Shakeel, Faisal, Shareef, Rabeea, Shah, Nazia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6060516/ https://www.ncbi.nlm.nih.gov/pubmed/30045715 http://dx.doi.org/10.1186/s12887-018-1211-y

Ejemplares similares

Exploratory Findings of Prescribing Unlicensed and Off-Label Medicines Among Children and Neonates
por: Shakeel, Sadia, et al.
Publicado: (2020)

Pattern and extent of off-label and unlicensed drug use in neonatal intensive care units in Iran
por: Kouti, Leila, et al.
Publicado: (2019)

Prescription of off-label and unlicensed drugs for preterm infants in a neonatal intensive care unit
por: Vieira, Verônica Cheles, et al.
Publicado: (2021)

Use of off-label and unlicensed medicines in neonatal intensive care
por: Costa, Haline Tereza Matias de Lima, et al.
Publicado: (2018)

Off-label and unlicensed drug use in Ayder comprehensive specialized hospital neonatal intensive care unit
por: Gidey, Meles Tekie, et al.
Publicado: (2020)

Clinical Setting Influences Off-Label and Unlicensed Prescribing in a Paediatric Teaching Hospital
por: Czarniak, Petra, et al.
Publicado: (2015)

Incidence of unlicensed and off-label prescription in children
por: Langerová, Petra, et al.
Publicado: (2014)

Safety and Efficacy of Off-label and Unlicensed Medicines in Children
por: Lee, Ji-Hyun, et al.
Publicado: (2018)

Off‐label and unlicensed medicines to hospitalised children in Norway
por: Teigen, Arna, et al.
Publicado: (2016)

Cross-sectional survey of off-label and unlicensed prescribing for inpatients at a paediatric teaching hospital in Western Australia
por: Landwehr, Caitlin, et al.
Publicado: (2019)

Unlicensed drug use on ICU
por: Goldsmith, C, et al.
Publicado: (2002)

High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.—Oct. 2014
por: Tukayo, Brechkerts Lieske Angruni, et al.
Publicado: (2020)

The Unlicensed and Off-Label Prescription of Medications in General Paediatric Ward: An Observational Study
por: Dornelles, Alícia Dorneles, et al.
Publicado: (2019)

Prescription of off-label and unlicensed medication for newborns hospitalized in the Intensive Care Unit
por: dos Santos, Laura Goedel, et al.
Publicado: (2023)

Patterns and Predictors of Off-Label Drug Prescribing in Psychiatric Practice: A Qualitative Study
por: Shakeel, Sadia, et al.
Publicado: (2021)

Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms
por: Binson, Guillaume, et al.
Publicado: (2021)

Adverse drug reactions and off-label and unlicensed medicines in children: a nested case?control study of inpatients in a pediatric hospital
por: Bellis, Jennifer R, et al.
Publicado: (2013)

Epidemiology of potential drug-drug interactions in elderly population admitted to critical care units of Peshawar, Pakistan
por: Shakeel, Faisal, et al.
Publicado: (2018)

Off-Label Use vs Off-Label Marketing of Drugs: Part 1: Off-Label Use—Patient Harms and Prescriber Responsibilities
por: Van Norman, Gail A.
Publicado: (2023)

Risk of potential drug-drug interactions in the cardiac intensive care units: A comparative analysis between 2 tertiary care hospitals
por: Shakeel, Faisal, et al.
Publicado: (2018)

Unlicensed Practitioners
Publicado: (1868)

Unlicensed Practitioners
Publicado: (1887)

The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine
por: Wang, Bo, et al.
Publicado: (2017)

Lunatics in Unlicensed Houses
Publicado: (1897)

Future Is Unlicensed: Private 5G Unlicensed Network for Connecting Industries of Future
por: Bajracharya, Rojeena, et al.
Publicado: (2020)

Off-label drugs for obesity
por: Morgan, Andy, et al.
Publicado: (2022)

Supporting patients with unlicensed medicine use: Analysing the script schemas for prescribing, pharmaceutical assessment and supply
por: Donovan, Gemma, et al.
Publicado: (2021)

Automated Detection of Off-Label Drug Use
por: Jung, Kenneth, et al.
Publicado: (2014)

Pediatric Off-Label COVID-19 Vaccination: The Concerns of Healthcare Professionals in Pakistan
por: Shakeel, Sadia, et al.
Publicado: (2022)

Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines
por: Kaiser, Peter K., et al.
Publicado: (2012)

Off-label prescribing for allergic diseases in children
por: Silva, Diana, et al.
Publicado: (2014)

Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use
por: Pesiou, Stella, et al.
Publicado: (2023)

Off-label drugs for weight management
por: Hendricks, Ed J
Publicado: (2017)

Knowledge on Multi-Drug Resistant Pathogens, Antibiotic Use and Self-Reported Adherence to Antibiotic Intake: A Population-Based Cross Sectional Survey From Pakistan
por: Arshad, Hafsa, et al.
Publicado: (2022)

Long term evolution in unlicensed bands
por: Ho, Quang-Dung, et al.
Publicado: (2016)

Awareness and Views of Pharmacists and Physicians Toward Prescribing of Drugs for Off-Label Use in the Pediatric Population in Saudi Arabia
por: Alyami, Dawood, et al.
Publicado: (2022)

Erratum to: Balancing risk in ophthalmic prescribing: assessing the safety of anti-VEGF therapies and the risks associated with unlicensed medicines
por: Kaiser, Peter K., et al.
Publicado: (2013)

Off-label prescribing of antipsychotics: prescribing practices and clinical experiences of Finnish physicians
por: Rautio, N., et al.
Publicado: (2022)

Paediatric drug use with focus on off-label prescriptions at Swedish hospitals – a nationwide study
por: Kimland, E, et al.
Publicado: (2012)

The evolving role and utility of off-label drug use in multiple myeloma
por: Stoeckle, James H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_isjum28u9tnaqpf2flf50b6h9u